What is the incidence and treatment of leiomyosarcoma in young girls?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence and Treatment of Leiomyosarcoma in Young Girls

Leiomyosarcoma is extremely rare in young girls, with an incidence of less than 2 per 1,000 per year, and treatment should focus on wide surgical excision with negative margins as the primary intervention. 1

Epidemiology and Incidence

Leiomyosarcoma (LMS) is exceedingly uncommon in the pediatric population:

  • Soft tissue sarcomas as a group have an overall incidence of 4-5/100,000/year in Europe 1
  • Leiomyosarcoma specifically has an incidence of less than 1/100,000/year 1
  • In children, leiomyosarcoma represents an even smaller fraction of these already rare tumors
  • Most leiomyosarcomas occur in adults, particularly in perimenopausal and postmenopausal women 2
  • When occurring in children, there is no significant gender predilection (11 girls and 9 boys in one series) 3

Clinical Presentation in Young Girls

When leiomyosarcoma does occur in young girls, it typically presents as:

  • Small, localized tumors in soft tissues 3
  • Most commonly affecting:
    • Trunk (30%)
    • Head and neck (25%)
    • Lower limbs (25%)
    • Upper limbs (20%) 3
  • Median age of 12 years (range 4-15 years) in pediatric cases 3
  • Median tumor size of 2.5 cm (range 0.5-13 cm) 3
  • Rare cases of primary gastric leiomyosarcoma have been reported in adolescents 4

Pathological Features

Pediatric leiomyosarcomas have distinct pathological characteristics:

  • Majority (85%) are low-grade tumors 3
  • Show typical features of smooth muscle differentiation with fascicles of eosinophilic spindle cells with cigar-shaped nuclei 3
  • Immunohistochemically positive for:
    • Alpha-smooth muscle actin (89%)
    • HHF-35 (87%)
    • Desmin (61%) 3
  • Histologic criteria for malignancy include increased mitoses, cellular pleomorphism, and thrombotic degeneration 1, 2

Treatment Approach

The treatment of leiomyosarcoma in young girls should follow these principles:

  1. Surgical Management:

    • Wide local excision with negative margins is the mainstay of treatment 3, 5
    • Complete resection with negative microscopic margins is critical for prognosis 6
    • For visceral leiomyosarcoma (e.g., bladder), organ-preserving surgery such as partial cystectomy may be appropriate 7
  2. Adjuvant Therapy:

    • Radiation therapy may be considered for:
      • Incompletely resected tumors
      • High-grade lesions
      • Recurrent disease 6
    • Chemotherapy options include:
      • Doxorubicin-based regimens
      • Cisplatin-based regimens 6
    • For unresectable cases, combined chemotherapy and radiation therapy may provide disease control 7

Prognosis and Follow-up

Pediatric leiomyosarcoma has a distinct prognostic profile:

  • Generally more favorable than adult leiomyosarcoma 3
  • Relatively indolent behavior in most pediatric cases 3
  • 5-year overall survival rate of approximately 79% 6
  • 10-year survival rate decreases to approximately 49% 6
  • Late recurrences can occur, even beyond 10 years 6
  • Important prognostic factors include:
    • Tumor grade (high-grade tumors have worse prognosis)
    • Surgical margins (complete vs. incomplete resection)
    • Tumor size 6

Special Considerations

  • Multidisciplinary approach involving pediatric oncologists, surgeons, radiation oncologists, and pathologists is essential 1
  • Treatment should be carried out in reference centers for sarcomas with expertise in pediatric oncology 1
  • Long-term follow-up is critical due to the risk of late recurrences 6
  • Differential diagnosis includes infantile myofibromatosis, leiomyoma, monophasic synovial sarcoma, and spindle cell rhabdomyosarcoma 3

Genetic Considerations

In rare cases, leiomyosarcoma may be associated with genetic syndromes:

  • Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome due to FH gene mutations 1
  • Annual skin examinations are recommended for children with FH mutations to assess for cutaneous leiomyomas and changes suggestive of leiomyosarcoma 1

While leiomyosarcoma is extremely rare in young girls, awareness of its clinical presentation, appropriate diagnostic workup, and treatment principles is essential for optimal outcomes in these challenging cases.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Uterine Leiomyosarcoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Leiomyosarcoma of soft tissue in children: clinicopathologic analysis of 20 cases.

The American journal of surgical pathology, 1999

Research

Primary leiomyosarcoma of the breast: A case report and literature review.

International journal of surgery case reports, 2023

Research

Leiomyosarcoma in childhood and adolescence.

Annals of surgical oncology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.